Cell/Gene Therapies: US FDA Wants ‘Quantitative Correlation' Between Surrogate And Clinical Outcome, Former Reviewer Says
When it comes to accelerated approval, CBER's Peter Marks wants to stretch the rubber band but not snap it. • Source: Shutterstock